Related Experiment Video
Updated: Jan 29, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Severe pulmonary edema after pulmonary hypertension interventional surgery: case report and literature review
Tuo Shen1, Xingping Lv1, Chun Wang1
1Department of Critical Care Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Background:
Pulmonary hypertension caused by fibrosing mediastinitis often presents with clinical manifestations related to involvement of the pulmonary arteries, pulmonary veins, and bronchi. Interventional therapy has become an important treatment option; however, it carries a significant risk of complications. In this case, the patient developed severe pulmonary edema after intervention, which posed major challenges to clinical management.
Case Presentation:
A middle-aged man presented with recurrent cough, expectoration, chest tightness, and dyspnea. He was initially treated for chronic obstructive pulmonary disease, but his symptoms showed little improvement. Owing to severe pulmonary hypertension, he was referred to the Department of Respiratory Medicine, where right heart catheterization confirmed the diagnosis of fibrosing mediastinitis. He subsequently underwent balloon angioplasty of the left pulmonary artery. During a second admission, he received right pulmonary artery balloon angioplasty with stent implantation under right heart catheter guidance. Shortly after the procedure, he developed severe pulmonary edema complicated by shock and acute renal failure. Conservative treatment was unsuccessful, and veno-venous extracorporeal membrane oxygenation (VV-ECMO) was initiated. With ECMO support, circulation was stabilized through active fluid resuscitation, followed by careful adjustment of volume status. His pulmonary edema gradually resolved, and he was eventually discharged in full recovery.
Conclusion:
Pulmonary hypertension caused by fibrosing mediastinitis is associated with poor prognosis. Interventional therapy may improve symptoms and hemodynamics but carries the risk of complications such as pulmonary edema, vascular injury, restenosis, and in-stent thrombosis. In this case, the development of severe pulmonary edema was most likely related to insufficient evaluation of the pulmonary venous system and limitations in the diagnostic and therapeutic process. This emphasizes the importance of comprehensive assessment of pulmonary venous involvement before intervention.
More Related Videos
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...